NCT06126276 2026-04-16
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
10 trialsNCT06525740 2026-03-04
Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery
Mayo Clinic
Phase 4 Recruiting
NCT05556772 2025-12-16
Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic
Fred Hutchinson Cancer Center
Phase NA Active not recruiting
NCT06709534 2025-09-11
An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors
Emory University
Phase NA Recruiting
NCT04258631 2024-10-16
Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies
Mayo Clinic
Phase 4 Completed
NCT04593550 2023-11-21
Electroencephalographic Changes Under General Anesthesia in Patients With Gynecologic Cancers With and Without History of Chemotherapy
M.D. Anderson Cancer Center
Completed
NCT01597804 2020-07-23
Bathing Bundle Regimen in Reducing Gynecological Surgical Site Infection in Patients Undergoing Surgery
Roswell Park Cancer Institute
Phase NA Completed
NCT01356329 2016-05-13
Lovenox
National Guard Health Affairs
Phase 3 Suspended
NCT01784406 2016-01-15
PESU
Rigshospitalet, Denmark
Phase NA Completed
NCT01871688 2013-06-07
Pelvic Floor Rehabilitation for Gynecological Cancer Patients
Seoul National University Bundang Hospital
Phase 2/3 Unknown